Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19

Hospital admissions and mortality from the Coronavirus disease 2019 (COVID-19) pandemic are spreading throughout the world, and second and third waves are thought to be likely. Risk factors for severe COVID-19 include diabetes, chronic kidney disease and cardiovascular disease. Currently, there is n...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez-Fernandez, Beatriz, D’Marco, Luis, Górriz, Jose Luis, Jacobs-Cachá, Conxita, Kanbay, Mehmet, Luis-Lima, Sergio, Porrini, Esteban, Sarafidis, Pantelis, Soler, María José, Ortiz, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409231/
https://www.ncbi.nlm.nih.gov/pubmed/32605278
http://dx.doi.org/10.3390/jcm9072030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409231/
https://www.ncbi.nlm.nih.gov/pubmed/32605278
http://dx.doi.org/10.3390/jcm9072030

Ejemplares similares